Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut
Top Cited Papers
Open Access
- 1 January 2015
- journal article
- review article
- Published by Wiley in Mediators of Inflammation
- Vol. 2015 (1) , 628157
Abstract
The pathogenesis of inflammatory bowel disease (IBD) is multifactorial with data suggesting the role of a disturbed interaction between the gut and the intestinal microbiota. A defective mucosal barrier may result in increased intestinal permeability which promotes the exposition to luminal content and triggers an immunological response that promotes intestinal inflammation. IBD patients display several defects in the many specialized components of mucosal barrier, from the mucus layer composition to the adhesion molecules that regulate paracellular permeability. These alterations may represent a primary dysfunction in Crohn’s disease, but they may also perpetuate chronic mucosal inflammation in ulcerative colitis. In clinical practice, several studies have documented that changes in intestinal permeability can predict IBD course. Functional tests, such as the sugar absorption tests or the novel imaging technique using confocal laser endomicroscopy, allow an in vivo assessment of gut barrier integrity. Antitumor necrosis factor‐α (TNF‐α) therapy reduces mucosal inflammation and restores intestinal permeability in IBD patients. Butyrate, zinc, and some probiotics also ameliorate mucosal barrier dysfunction but their use is still limited and further studies are needed before considering permeability manipulation as a therapeutic target in IBD.Keywords
This publication has 149 references indexed in Scilit:
- Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future DirectionsCurrent Gastroenterology Reports, 2013
- Probiotic Bacteria Induce Maturation of Intestinal Claudin 3 Expression and Barrier FunctionThe American Journal of Pathology, 2012
- Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel diseaseGut, 2011
- Genetics and pathogenesis of inflammatory bowel diseaseNature, 2011
- The tight junction in inflammatory disease: communication breakdownCurrent Opinion in Pharmacology, 2009
- High-Fat Diet Determines the Composition of the Murine Gut Microbiome Independently of ObesityGastroenterology, 2009
- Nod2 is required for the regulation of commensal microbiota in the intestineProceedings of the National Academy of Sciences, 2009
- Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's diseaseNature Genetics, 2008
- Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibilityNature Genetics, 2007
- Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s diseaseGut, 2006